000 | 02003 a2200577 4500 | ||
---|---|---|---|
005 | 20250517194324.0 | ||
264 | 0 | _c20190520 | |
008 | 201905s 0 0 eng d | ||
022 | _a1538-7445 | ||
024 | 7 |
_a10.1158/0008-5472.CAN-17-0846 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNougarede, Adrien | |
245 | 0 | 0 |
_aBreast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10. _h[electronic resource] |
260 |
_bCancer research _c03 2018 |
||
300 |
_a1404-1417 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 |
_aEndoplasmic Reticulum _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInositol 1,4,5-Trisphosphate Receptors _xmetabolism |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
650 | 0 | 4 |
_aPeptide Fragments _xmetabolism |
650 | 0 | 4 |
_aPeptides _xpharmacology |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aPopgeorgiev, Nikolay | |
700 | 1 | _aKassem, Loay | |
700 | 1 | _aOmarjee, Soleilmane | |
700 | 1 | _aBorel, Stephane | |
700 | 1 | _aMikaelian, Ivan | |
700 | 1 | _aLopez, Jonathan | |
700 | 1 | _aGadet, Rudy | |
700 | 1 | _aMarcillat, Olivier | |
700 | 1 | _aTreilleux, Isabelle | |
700 | 1 | _aVilloutreix, Bruno O | |
700 | 1 | _aRimokh, Ruth | |
700 | 1 | _aGillet, Germain | |
773 | 0 |
_tCancer research _gvol. 78 _gno. 6 _gp. 1404-1417 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-17-0846 _zAvailable from publisher's website |
999 |
_c27976171 _d27976171 |